OPKO Health Gross Margin 2010-2024 | OPK

Current and historical gross margin for OPKO Health (OPK) over the last 10 years. The current gross profit margin for OPKO Health as of March 31, 2024 is %.
OPKO Health Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $0.80B $0.26B 32.63%
2023-12-31 $0.86B $0.32B 36.81%
2023-09-30 $0.87B $0.33B 37.95%
2023-06-30 $0.87B $0.31B 35.94%
2023-03-31 $0.91B $0.30B 33.08%
2022-12-31 $1.00B $0.29B 28.69%
2022-09-30 $1.22B $0.34B 27.95%
2022-06-30 $1.43B $0.45B 31.70%
2022-03-31 $1.56B $0.49B 31.19%
2021-12-31 $1.77B $0.58B 32.86%
2021-09-30 $1.87B $0.65B 34.80%
2021-06-30 $1.91B $0.66B 34.71%
2021-03-31 $1.77B $0.65B 36.86%
2020-12-31 $1.44B $0.54B 37.70%
2020-09-30 $1.16B $0.45B 38.40%
2020-06-30 $0.97B $0.38B 39.27%
2020-03-31 $0.89B $0.32B 36.18%
2019-12-31 $0.90B $0.33B 36.51%
2019-09-30 $0.90B $0.32B 35.48%
2019-06-30 $0.92B $0.33B 35.98%
2019-03-31 $0.96B $0.36B 37.89%
2018-12-31 $0.99B $0.39B 38.95%
2018-09-30 $0.93B $0.32B 34.19%
2018-06-30 $0.93B $0.31B 33.91%
2018-03-31 $0.96B $0.34B 35.08%
2017-12-31 $0.97B $0.35B 35.82%
2017-09-30 $0.98B $0.35B 36.27%
2017-06-30 $1.03B $0.41B 39.49%
2017-03-31 $1.09B $0.48B 43.50%
2016-12-31 $1.12B $0.51B 45.39%
2016-09-30 $1.22B $0.63B 51.39%
2016-06-30 $1.07B $0.56B 52.20%
2016-03-31 $0.75B $0.38B 50.66%
2015-12-31 $0.49B $0.26B 52.34%
2015-09-30 $0.24B $0.14B 57.26%
2015-06-30 $0.12B $0.07B 60.17%
2015-03-31 $0.10B $0.05B 54.00%
2014-12-31 $0.09B $0.04B 47.83%
2014-09-30 $0.09B $0.04B 44.83%
2014-06-30 $0.09B $0.04B 44.32%
2014-03-31 $0.09B $0.04B 44.32%
2013-12-31 $0.10B $0.05B 50.52%
2013-09-30 $0.09B $0.05B 51.09%
2013-06-30 $0.08B $0.04B 50.60%
2013-03-31 $0.07B $0.04B 50.72%
2012-12-31 $0.05B $0.02B 40.43%
2012-09-30 $0.04B $0.01B 37.84%
2012-06-30 $0.03B $0.01B 40.63%
2012-03-31 $0.03B $0.01B 43.33%
2011-12-31 $0.03B $0.01B 42.86%
2011-09-30 $0.03B $0.02B 62.07%
2011-06-30 $0.03B $0.02B 60.71%
2011-03-31 $0.03B $0.02B 59.26%
2010-12-31 $0.03B $0.02B 53.57%
2010-09-30 $0.02B $0.01B 36.84%
2010-06-30 $0.02B $0.01B 33.33%
2010-03-31 $0.01B $0.00B 30.00%
2009-12-31 $0.00B $0.00B 50.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.039B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $203.970B 24.72
Intuitive Surgical (ISRG) United States $161.392B 91.55
Edwards Lifesciences (EW) United States $52.125B 33.92
DexCom (DXCM) United States $44.405B 67.27
Alcon (ALC) Switzerland $44.397B 31.81
IQVIA Holdings (IQV) United States $40.917B 23.74
IDEXX Laboratories (IDXX) United States $38.667B 45.32
STERIS (STE) Ireland $22.172B 25.90
Hologic (HOLX) United States $18.229B 20.39
Waters (WAT) United States $17.957B 26.39
SONOVA HOLDING (SONVY) Switzerland $17.634B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.555B 13.49
Teleflex (TFX) United States $10.447B 16.26
Sysmex ADR (SSMXY) Japan $10.171B 31.89
Globus Medical (GMED) United States $9.832B 28.82
Penumbra (PEN) United States $7.360B 83.64
Glaukos (GKOS) United States $6.081B 0.00
Masimo (MASI) United States $5.678B 32.65
TransMedics (TMDX) United States $4.848B 460.00
Integer Holdings (ITGR) United States $4.225B 25.53
PROCEPT BioRobotics (PRCT) United States $3.470B 0.00
Inari Medical (NARI) United States $3.192B 0.00
LivaNova (LIVN) United Kingdom $2.865B 17.01
Tandem Diabetes Care (TNDM) United States $2.820B 0.00
Integra LifeSciences Holdings (IART) United States $2.470B 10.77
Veracyte (VCYT) United States $1.772B 0.00
RxSight (RXST) United States $1.730B 0.00
Alphatec Holdings (ATEC) United States $1.551B 0.00
Artivion (AORT) United States $1.135B 108.88
Silk Road Medical (SILK) United States $1.068B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.009B 19.63
Pulse Biosciences (PLSE) United States $0.977B 0.00
OrthoPediatrics (KIDS) United States $0.776B 0.00
SiBone (SIBN) United States $0.684B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
Mesa Laboratories (MLAB) United States $0.585B 17.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.580B 0.00
IRadimed (IRMD) United States $0.572B 32.06
Treace Medical Concepts (TMCI) United States $0.489B 0.00
Pacific Biosciences Of California (PACB) United States $0.452B 0.00
AxoGen (AXGN) United States $0.399B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
Nevro (NVRO) United States $0.334B 0.00
Tactile Systems Technology (TCMD) United States $0.294B 10.07
AngioDynamics (ANGO) United States $0.288B 0.00
Semler Scientific (SMLR) United States $0.237B 12.02
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.229B 0.00
Inogen (INGN) United States $0.218B 0.00
CVRx (CVRX) United States $0.202B 0.00
ClearPoint Neuro (CLPT) United States $0.194B 0.00
EDAP TMS S.A (EDAP) France $0.189B 0.00
908 Devices (MASS) United States $0.186B 0.00
Accuray (ARAY) United States $0.179B 0.00
Atossa Genetics (ATOS) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.146B 0.00
KORU Medical Systems (KRMD) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.098B 20.69
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Hyperfine (HYPR) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.075B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Neuronetics (STIM) United States $0.058B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.027B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00